Eric Vivier Explained

Eric Vivier
Birth Place:Clamart. France
Fields:Immunology

Eric Vivier is a French professor of immunology at Aix-Marseille and hospital practitioner[1] at Marseille Public University Hospital. He is also Chief Scientific Officer at Innate Pharma,[2] coordinator of the Marseille Immunopôle immunology cluster,[3]  and president of the Paris-Saclay Cancer Cluster, the first biocluster selected by the French government as part of the France 2030 program.[4] [5]

Biography

Vivier was born in Clamart, France.[6] He graduated from the Ecole Nationale Vétérinaire de Maisons-Alfort and received his doctoral degree in immunology from Paris XI University. He began his postdoctoral training as a Fogarty International Center Research Fellow at Harvard Medical School with Paul J. Anderson and Stuart F. Schlossman (the Dana-Farber Cancer Institute).[7] [8]

He joined Aix-Marseille University as a professor at the Centre d'Immunologie de Marseille-Luminy (CIML) in 1993, becoming its director in 2008[9] until 2017. Vivier is one of four immunologists whose research led to the creation of the biotech company Innate-Pharma in 1999.[10] In 2014, he was also one of the founders of the Marseille-Immunopole,[11] [12] [13] an immunology cluster linking fundamental research, therapeutic innovation, and industrial development in the Aix-Marseille region.

In addition to his academic activities, he became the chief scientific officer of Innate Pharma in January 2018. In 2022, he took over the presidency of the PSCC (Paris Saclay Cancer Cluster), designated in December 2022 as the first winner of the "Biocluster" call for expressions of interest under the France 2030 program launched by the French government to promote investment, innovation and re-industrialization.[14]

Scientific insights

Vivier has made contributions to the understanding of the molecular basis of the ontogeny, function, and therapeutic manipulation of natural killer (NK) cells,[15] [16] and the identification of innate lymphoid cells (ILCs) in mice and humans.[17] His research has had a profound influence on the field of innate immunology.[18] [19] [20] [21]

His early work had determined the mode of action of the inhibitory MHC class I receptors expressed on NK cells and extended the concept of ITIM-bearing molecules to multiple cell types and multiple biologic functions. In parallel, his group identified the ITAM-bearing polypeptide, KARAP/DAP12/Tyrobp.[22]

These studies on NK cells led to the involvement of the Vivier laboratory in the discovery of ILCs through the detection and characterization of the ILC3 cell subset in human and mouse intestines.

Vivier has published more than 300 scientific articles[23] and is on the editorial boards of leading peer-reviewed journals. He serves on the expert panel of the European Research Council and the committees of pharmaceutical and biotechnology companies.[24] [25] [26] [27]

Awards and honours

In 2007, Vivier became a senior fellow of the Institut Universitaire de France, and, in 2013, he was elected to the French National Academy of Medicine. 

In 2016, he was awarded honorary citizen of the city of Cassis, Chevalier de la Légion d’Honneur[35] and Ambassadeur de la ville de Marseille.[36]

Current positions

External links

Notes and References

  1. Web site: Laboratoire d'immunologie - Hôpital de la Conception AP-HM . 2018-01-11 . fr.ap-hm.fr . fr.
  2. News: Marseille : le Professeur Éric Vivier retrouve Innate Pharma .
  3. News: Communauté : Marseille immunopôle . fr . Marseille Immunopôle . 2018-01-11.
  4. Web site: Innovation Paris Saclay Cancer Cluster . 2023-01-10 . PSCC . fr.
  5. Web site: 2022-08-29 . Le Paris Saclay cancer cluster veut dynamiser la création de start-up françaises en oncologie . 2023-01-10 . Le journal du Grand Paris - L'actualité du développement de l'Ile-de-France . fr-FR.
  6. Web site: Eric Vivier - Who's Who. www.whoswho.fr. fr. 2017-03-14.
  7. News: Professor Eric Vivier - Centre d'Immunologie de Marseille-Luminy. 2015-01-19. Walter and Eliza Hall Institute of Medical Research. 2017-03-14. en.
  8. 2015-10-01. Cancer Immunology Research: 3 (10). Cancer Immunology Research. en. 3. 10. 2326-6066.
  9. Web site: APMnews - Le Pr Eric Vivier nommé directeur du Centre d'immunologie Marseille-Luminy. www.apmnews.com. fr. 2018-01-11.
  10. Web site: Founders Innate Pharma. innate-pharma.com. en. 2017-02-16.
  11. News: Accueil : Marseille immunopôle. Marseille Immunopôle. 2017-02-16. fr.
  12. News: Immunopole : l'exception marseillaise. Le Monde.fr. 2017-03-14. fr-FR.
  13. Web site: Cancer : la recherche française séduit les industriels étrangers. 2016-04-12. lesechos.fr. 2017-03-14.
  14. Web site: France 2030 : « Paris Saclay Cancer Cluster », premier lauréat de l'AMI « Biocluster » . 2023-01-10 . enseignementsup-recherche.gouv.fr . fr.
  15. News: Que suis-je : la philo bouscule la biologie. Le Monde.fr. 2017-03-14. fr-FR.
  16. News: Une cellule tueuse mutante à l'assaut des virus. Le Monde.fr. 2017-03-14. fr-FR.
  17. Web site: Les cellules innées lymphoïdes: système de secours contre les infections de l'intestin. www.inserm.fr. fr-FR. 2017-03-14. https://web.archive.org/web/20170311083407/http://www.inserm.fr/layout/set/print/espace-journalistes/les-cellules-innees-lymphoides-systeme-de-secours-contre-les-infections-de-l-intestin. 2017-03-11. dead.
  18. Web site: sciences.blogs.liberation.fr - Une piste pour booster l'immunité ? - Libération.fr. Huet. Sylvestre. sciences.blogs.liberation.fr. fr. 2017-03-14.
  19. News: Ces drôles de pieuvres dans notre sang. Le Monde.fr. 2017-03-14. fr-FR.
  20. News: Les tueuses de l'immunité innée. Pourlascience.fr. 2017-03-14. fr-FR.
  21. Web site: Infections: Inactiver un gène pour stimuler le système immunitaire? – Inserm et Science –. 20 January 2012. 2017-03-14.
  22. Tomasello. Elena. Vivier. Eric. 2005-06-01. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. European Journal of Immunology. en. 35. 6. 1670–1677. 10.1002/eji.200425932. 15884055. 45371614. 1521-4141. free.
  23. Web site: Eric Vivier - Citations Google Scholar. scholar.google.fr. 2017-03-14.
  24. Web site: Eric Vivier.
  25. Web site: a typo|comi|ttee}}/ Steering Committee: Antibodies for Medicine. www.mimabs.org. en. 2017-03-14.
  26. Web site: Comité Scientifique de la Fondation BMS pour la Recherche en Immuno-Oncologie. fondation-bms.fr. fr. 2017-03-14.
  27. News: Management - Bioaster. Bioaster. 2017-03-14. en-GB.
  28. Web site: Prix DUQUESNE 2013 du Comité de Paris de la Ligue Nationale contre le Cancer. www.paca.inserm.fr. fr-FR. 2017-03-14.
  29. Web site: Les prix de la fondation pour la recherche médicale. 2017-03-14. https://web.archive.org/web/20160303221746/http://www.cnrs.fr/insb/recherche/prix/2007/PrixFRM2007.pdf. 2016-03-03. dead.
  30. Web site: Société Française d'Immunologie. www.sfi-immunologie.com.fr. en. 2017-03-14.
  31. Web site: EFIS – European Federation of Immunological Societies: EFIS-IL Lecture Award. www.efis.org. en. 2017-03-14.
  32. Web site: Prix René Turpin.
  33. Web site: Les membres - Institut Universitaire de France. www.iufrance.fr. fr. 2017-03-14.
  34. Web site: Awards.
  35. Web site: Eric Vivier est promu dans l'ordre de la Légion d'honneur au grade de chevalier CIML. www.ciml.univ-mrs.fr. en. 2017-03-14.
  36. Web site: Les ambassadeurs – Accueil – ClubM. clubm.marseille.fr. fr-FR. 2017-03-14.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Eric Vivier".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.